Journal profile · Pathology
Neuropathology
ISSN 0919-6544 · eISSN 1440-1789 · Wiley-Blackwell Publishing Ltd · AUSTRALIA · Quarterly · Founded 1993
Neuropathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.3; hybrid open access; APC about USD 3,400; median 96 days to acceptance (76 articles, last 24 months); community-reported acceptance: fairly easy; 67 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Neuropathology is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glioma Diagnosis and Treatment, Legal and Regulatory Analysis and Linguistic, Cultural, and Literary Studies, together about 29.7% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Neuropathology is an international journal sponsored by the Japanese Society of Neuropathology and publishes peer-reviewed original papers dealing with all aspects of human and experimental neuropathology and related fields of research. The Journal aims to promote the international exchange of results and encourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Short Communications, Occasional Reviews, Editorials and Letters to the Editor. All articles are peer-reviewed by at least two researchers expert in the field of the submitted paper.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Masaki TakaoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glioma Diagnosis and TreatmentMedicine11.3%
- Legal and Regulatory AnalysisSocial Sciences9.2%
- Linguistic, Cultural, and Literary StudiesSocial Sciences9.2%
- Military Technology and StrategiesEngineering9.2%
- Parkinson's Disease Mechanisms and TreatmentsMedicine6.5%
- Alzheimer's disease research and treatmentsMedicine5.7%
- Neurological diseases and metabolismNeuroscience5.5%
- Amyotrophic Lateral Sclerosis ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbasePublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.3LetPub ·
- Impact factor (publisher)
- 1.3Publisher website ·
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- CiteScore (publisher)
- 2.7Publisher website ·
- CiteScore (publisher) 2025
- 2.7Publisher website ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.66LetPub ·
- h-index
- 54LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 1,112OpenAlex ·
- 2-year mean citedness
- 1.27OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 22.92%LetPub ·
Volume
- Articles per year
- 44LetPub ·
- Articles per year (publisher) 2025
- 48Publisher website ·
- Downloads per year (publisher) 2025
- 140,787Publisher website ·
Articles by year OpenAlex count · 4,017 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 18 | 6 |
| 2025 | 67 | 31 | 76 |
| 2024 | 70 | 37 | 145 |
| 2023 | 77 | 48 | 230 |
| 2022 | 113 | 21 | 586 |
| 2021 | 74 | 18 | 468 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
96 daysMedian, submission to acceptance · P25–P75 51 days – 137 days
- Acceptance to online
- median 14 days (77 articles)
- Submission to online
- median 112 days
- Sample
- 76 articles with submission and acceptance dates (125 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 20%Publisher website ·
- Acceptance rate (publisher) 2025
- 20%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to first decision 2025
- 2 daysPublisher website ·
- Submission to acceptance 2025
- 89 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Single-anonymous peer review, at least 2 reviewersPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,400 / EUR 2,870 / GBP 2,270 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- 5
- Reference style
- Chicago
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted6
- case reportsencourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Occasional Reviews, Editorials and Letters …Length not stated
- editorialThe acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Manuscripts are accepted whether …Length not stated
- editorialsencourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Occasional Reviews, Editorials and Letters …Length not stated
- letters to the editorencourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Occasional Reviews, Editorials and Letters …Length not stated
- occasional reviewsencourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Occasional Reviews, Editorials and Letters …Length not stated
- original articlesencourages authors from all countries to submit papers in the following categories: Original Articles, Case Reports, Occasional Reviews, Editorials and Letters …Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Plagiarism, Preprints
- Authorship Authorship and Acknowledgement
The editors of Neuropathology subscribe to the recommendations formulated by the ICMJE regarding criteria for authorship. Accordingly, each person listed as an author or co-author for all submitted manuscripts must meet all the following criteria. An author or co-author shall have:1) substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of da…
Source ↗Publisher website ·- Conflicts of interest Disclosure
All authors should declare any financial support or relationship(s) that may pose a conflict of interest in Disclosure section. A Conflict of Interest 3 statement needs to be supplied and will be included as part of the published paper before the reference using the following format. Author A.Y. (by Name) was supported by grants or donations from xxx etc., author A. Y has a leadership role in a pr…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Model summary
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Brazil 2013), available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involvi…
Source ↗Publisher website ·- License & copyright COPYRIGHT LICENSING AND OPEN ACCESS
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. Authors may to publish u…
Source ↗Publisher website ·- Open access COPYRIGHT LICENSING AND OPEN ACCESS
Open Access authors retain copyright and choose among CC BY, CC BY NC, CC BY NC ND licenses. Model summary
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. Authors may to publish u…
Source ↗Publisher website ·- Plagiarism
CrossCheck plagiarism software is used. Model summary
Neuropathology has adopted CrossCheck plagiarism software.
Source ↗Publisher website ·- Preprints PREPRINT POLICY
Preprint policy: journal accepts articles previously published on preprint servers; submitted versions may be posted to preprint servers at any time. Model summary
Please find the Wiley preprint policy here. This journal accepts articles previously published on preprint servers. Neuropathology will consider for review articles previously available as preprints. You may also post the submitted version of a manuscript to a preprint server at any time. You are requested to update any pre-publication versions with a link to the final published article.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- AUSTRALIA
- Language
- English
- Frequency
- Quarterly
- Founded
- 1993
- ISSN
- 0919-6544
- Electronic ISSN
- 1440-1789
- Society / sponsor
- Japanese Society of Neuropathology
- Latest issue on the website
- Volume 46, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Neuropathology
What CAS zone is Neuropathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neuropathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Neurosciences / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neuropathology?
The latest impact factor listed by LetPub is 1.3; CiteScore 2.7, h-index 83.
How long does peer review take at Neuropathology?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 51–137 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 20% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Neuropathology?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: 5; Reference style: Chicago; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Neuropathology?
According to LetPub and DOAJ records, Neuropathology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is Neuropathology open access, and what is the APC?
Neuropathology is a hybrid journal. For open-access publication: APC about USD 3,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .